Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05006040 · ClinicalTrials.gov registry record · Early Phase 1
HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL
A Early Phase 1 study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT05006040 is a Early Phase 1 study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 1 participants.
The verdict
NCT05006040, a Early Phase 1 study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The overall objective of this pilot study is to determine the safety and feasibility of a hybrid closed-loop insulin delivery system for children and young adults with high risk acute lymphoblastic leukemia, during the induction chemotherapy phase while they are exposed to steroids and asparaginase that cause hyperglycemia.
Interventions
- DEVICE Hybrid Closed Loop System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-05-12 |
| Est. Completion | 2023-08-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05006040
The ClinicalTrials.gov registry entry for NCT05006040 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hybrid Closed Loop System is the first listed.
NCT05006040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05006040 about?
NCT05006040 is a clinical study titled "HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL". The overall objective of this pilot study is to determine the safety and feasibility of a hybrid closed-loop insulin delivery system for children and young adults with high risk acute lymphoblastic leukemia, during the induction chemotherapy phase while they are exposed to steroids and asparaginase ...
What is the current status of trial NCT05006040?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2022-05-12. Estimated completion is 2023-08-01.
What interventions are being tested in trial NCT05006040?
The interventions under investigation include: Hybrid Closed Loop System (DEVICE).
Who is sponsoring clinical trial NCT05006040?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.